SNIPR BIOME initiates first-in-human clinical trial with SNIPR001
The purpose of the study is to investigate safety and tolerability of SNIPR001 in healthy volunteers and to evaluate the effect of SNIPR001 on reducing E. coli colonization in the gut
The purpose of the study is to investigate safety and tolerability of SNIPR001 in healthy volunteers and to evaluate the effect of SNIPR001 on reducing E. coli colonization in the gut
Bionova Scientific’s process development capabilities are particularly highly regarded in the industry, and it has a rich track record regarding complex next-generation antibody drugs, which are typically challenging to manufacture
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
Approval for primary and booster immunization is based on efficacy and safety data from Japan and international clinical studies
New product line to address the challenge of restrictions on use of plastic straws
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
India-Sweden Healthcare Innovation Centre in collaboration with AIIMS Jodhpur and AstraZeneca India launches an e-learning Upskilling Program in Diabetes Management for nurses
The HD-550 endoscopy system has been available outside of the USA since 2019
This marks an expansion of the companies' existing collaboration and further validates the use of Albumedix Recombumin rHA products in the manufacturing process and final formulation of critical vaccines
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
Subscribe To Our Newsletter & Stay Updated